相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Antibodies to Mycobacterium paratuberculosis-specific protein antigens in Crohn's disease
A. ELSAGHIER et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Detection of Mycobacterium avium subspecies paratuberculosis from patients with Crohn's disease using nucleic acid-based techniques: A systematic review and meta-analysis
I. Abubakar et al.
INFLAMMATORY BOWEL DISEASES (2008)
Characterization, of epithelial IL-8 response to inflammatory bowel disease mucosal E-coli and its inhibition by mesalamine
Sreedhar Subramanian et al.
INFLAMMATORY BOWEL DISEASES (2008)
Mycobacterium avium subspecies paratuberculosis infection in cases of irritable bowel syndrome and comparison with Crohn's disease and Johne's disease:: Common neural and immune pathogenicities
Antonio M. Scanu et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
A meta-analysis of antibiotic therapy for active ulcerative colitis
Roja Rahimi et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
Microbial mannan inhibits bacterial killing by macrophages: A possible pathogenic mechanism for Crohn's disease
Chiedzo M. Mpofu et al.
GASTROENTEROLOGY (2007)
Invasive Escherichia coli are a feature of Crohn's disease
Maiko Sasaki et al.
LABORATORY INVESTIGATION (2007)
Adherent-invasive Escherichia coli in inflammatory bowel disease
Nathalie Rolhion et al.
INFLAMMATORY BOWEL DISEASES (2007)
Mycobacterium paratuberculosis is recognized by Toll-like receptors and NOD2
Gerben Ferwerda et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease
Roman Kotlowski et al.
GUT (2007)
Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006
S. L. Jakobovits et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Molecular evidence for Mycobacterium avium subspecies paratuberculosis (MAP) in Crohn's disease correlates with enhanced TNF-α secretion
R. Clancy et al.
DIGESTIVE AND LIVER DISEASE (2007)
Structural shifts of mucosa-associated lactobacilli and Clostridium leptum subgroup in patients with ulcerative colitis
Meiling Zhang et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
Multicenter randomized-control led clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after ileo-caecal resection
Andre Van Gossum et al.
INFLAMMATORY BOWEL DISEASES (2007)
Failure of synbiotic 2000 to prevent postoperative recurrence of Crohn's disease
Irit Chermesh et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
Mycobacterium avium subspecies paratuberculosis and Crohn's disease: a systematic review and meta-analysis
Martin Feller et al.
LANCET INFECTIOUS DISEASES (2007)
A meta-analysis of broad-spectrum antibiotic therapy in patients with active Crohn's disease
Roja Rahimi et al.
CLINICAL THERAPEUTICS (2006)
Abnormal microbiota composition in the ileocolonic mucosa of Crohn's disease patients as revealed by polymerase chain reaction-denaturing gradient gel electrophoresis
Margarita Martinez-Medina et al.
INFLAMMATORY BOWEL DISEASES (2006)
Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease
M. P. Conte et al.
GUT (2006)
Bacteria in the pathogenesis of inflammatory bowel disease
Sreedhar Subramanian et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2006)
Ciprofloxacin inhibits cytokine-induced nitric oxide production in human colonic epithelium
G. Kolios et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2006)
The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn's disease and ulcerative colitis patients
Rodrigo Bibiloni et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2006)
Evaluation of in situ methods used to detect Mycobacterium avium subsp paratuberculosis in samples from patients with Crohn's disease
Mangalakurnari Jeyanathan et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease:: a randomised, double blind, placebo controlled GETAID trial
P. Marteau et al.
GUT (2006)
Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis
M. A. Zocco et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Antibiotic treatment of Crohn's disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin
C Prantera et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn's disease
JO Lindsay et al.
GUT (2006)
Defective acute inflammation in Crohn's disease: a clinical investigation
DJB Marks et al.
LANCET (2006)
Specificities of the fecal microbiota in inflammatory bowel disease
H Sokol et al.
INFLAMMATORY BOWEL DISEASES (2006)
Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach
C Manichanh et al.
GUT (2006)
Experimental and clinical pharmacology of rifaximin, a gastrointestinal selective antibiotic
C Scarpignato et al.
DIGESTION (2006)
Effectiveness of antibiotic combination therapy in patients with active ulcerative colitis: A randomized, controlled pilot trial with long-term follow-up
T Ohkusa et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2005)
Maintenance therapy with a probiotic in antibiotic-dependent pouchitis: experience in clinical practice
B Shen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Mycobacterium avium subsp paratuberculosis, genetic susceptibility to Crohn's disease, and Sardinians:: the way ahead
LA Sechi et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
A randomized, double-blind trial of lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease
A Bousvaros et al.
INFLAMMATORY BOWEL DISEASES (2005)
VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis
R Bibiloni et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Detection and isolation of Mycobacterium avium subspecies paratuberculosis from intestinal mucosal biopsies of patients with and without Crohn's disease in Sardinia
LA Sechi et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Molecular characterization of rectal mucosa-associated bacterial flora in inflammatory bowel disease
M Mylonaki et al.
INFLAMMATORY BOWEL DISEASES (2005)
Probiotic therapy in the prevention of pouchitis onset:: Decreased interleukin-1β, interleukin-8, and interferon-γ gene expression
KM Lammers et al.
INFLAMMATORY BOWEL DISEASES (2005)
Mucosa-associated bacteria in ulcerative colitis before and after antibiotic combination therapy
T Nomura et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: A randomized, double-blind, placebo-controlled trial
P Rutgeerts et al.
GASTROENTEROLOGY (2005)
Association between fecal hydrogen sulfide production and pouchitis
H Ohge et al.
DISEASES OF THE COLON & RECTUM (2005)
Associations between diet and disease activity in ulcerative colitis patients using a novel method of data analysis
Elizabeth A. Magee et al.
NUTRITION JOURNAL (2005)
Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis:: a randomised controlled pilot trial
E Furrie et al.
GUT (2005)
Oral Pentasa in the Treatment of Active Crohn's Disease: A Meta-Analysis of Double-Blind, Placebo-Controlled Trials
Stephen B. Hanauer et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2004)
Identification and quantitation of mucosal and faecal desulfovibrios using real time polymerase chain reaction
A Fite et al.
GUT (2004)
Lactobacillus GG in inducing and maintaining remission of Crohn's disease
M Schultz et al.
BMC GASTROENTEROLOGY (2004)
Population-based case control study of seroprevalence of Mycobacterium paratuberculosis in patients with Crohn's disease and ulcerative colitis
CN Bernstein et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Systematic review: short-term adverse effects of 5-aminosalicylic acid agents in the treatment of ulcerative colitis
EV Loftus et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease
SA Naser et al.
LANCET (2004)
Guidelines for the management of inflammatory bowel disease in adults
MJ Carter et al.
GUT (2004)
High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease
A Darfeuille-Michaud et al.
GASTROENTEROLOGY (2004)
Assessment of mucosal inflammation and blood flow in response to four weeks' intervention with probiotics in patients operated with a J-configurated ileal-pouch-anal-anastomosis (IPAA)
KO Laake et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2004)
Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer
HM Martin et al.
GASTROENTEROLOGY (2004)
Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis
K Kato et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Chemotaxonomic analysis of bacterial populations colonizing the rectal mucosa in patients with ulcerative colitis
S Macfarlane et al.
CLINICAL INFECTIOUS DISEASES (2004)
Dysbiosis in inflammatory bowel disease
CP Tamboli et al.
GUT (2004)
Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis
T Mimura et al.
GUT (2004)
Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine
W Kruis et al.
GUT (2004)
Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota
S Bartosch et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2004)
Infliximab in inflammatory bowel disease:: clinical outcome in a population based cohort from Stockholm County
T Ljung et al.
GUT (2004)
Delay of the first onset of pouchitis by oral intake of the Probiotic strain Lactobacillus rhamnosus GG
MP Gosselink et al.
DISEASES OF THE COLON & RECTUM (2004)
Comparison of compositions and metabolic activities of fecal microbiotas in young adults and in antibiotic-treated and non-antibiotic-treated elderly subjects
EJ Woodmansey et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2004)
From symptom to diagnosis: Clinical distinctions among various forms of intestinal inflammation
BE Sands
GASTROENTEROLOGY (2004)
Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease
SJ Ott et al.
GUT (2004)
Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences
EV Loftus
GASTROENTEROLOGY (2004)
Detection and verification of Mycobacterium avium subsp paratuberculosis in fresh ileocolonic mucosal biopsy specimens from individuals with and without Crohn's disease
TJ Bull et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Treatment of ulcerative colitis using fecal bacteriotherapy
TJ Borody et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2003)
A pilot trial of Saccharomyces boulardii in ulcerative colitis
M Guslandi et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2003)
Prophylaxis of pouchitis onset with probiotic therapy: A double-blind, placebo-controlled trial
P Gionchetti et al.
GASTROENTEROLOGY (2003)
Comparison of Lactobacillus Gg and mesalazine in maintaining remission of ulcerative colitis and Crohn's disease
MA Zocco et al.
GASTROENTEROLOGY (2003)
Ciclosporin and refractory colitis
AB Hawthorne
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2003)
Methotrexate: first-line or second-line immunomodulator?
AG Fraser
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2003)
Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon
P Seksik et al.
GUT (2003)
Effect of Lactobacillus rhamnosus GG on ileal pouch inflammation and microbial flora
J Kuisma et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis
H Ishikawa et al.
JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION (2003)
Regulation of expression of beta-defensins: endogenous enteric peptide antibiotics
DA O'Neil
MOLECULAR IMMUNOLOGY (2003)
Induction of experimental ulcerative colitis by Fusobacterium varium isolated from colonic mucosa of patients with ulcerative colitis
T Ohkusa et al.
GUT (2003)
Increased mucosal tumour necrosis factor α production in Crohn's disease can be downregulated ex vivo by probiotic bacteria
N Borruel et al.
GUT (2002)
Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease:: a randomised controlled trial with Lactobacillus GG
C Prantera et al.
GUT (2002)
Combined budesonide and antibiotic therapy for active Crohn's disease: a randomized controlled trial
AH Steinhart et al.
GASTROENTEROLOGY (2002)
Effects of rifaximin administration on the intestinal microbiota in patients with ulcerative colitis
P Brigidi et al.
JOURNAL OF CHEMOTHERAPY (2002)
Effect of dietary inulin supplementation on inflammation of pouch mucosa in patients with an heal pouch-anal anastomosis
CFM Welters et al.
DISEASES OF THE COLON & RECTUM (2002)
Open clinical trial of rifabutin and clarithromycin therapy in Crohn's disease
I Shafran et al.
DIGESTIVE AND LIVER DISEASE (2002)
Mucosal flora in inflammatory bowel disease
A Swidsinski et al.
GASTROENTEROLOGY (2002)
Preliminary study of ciprofloxacin in active Crohn's disease
GL Arnold et al.
INFLAMMATORY BOWEL DISEASES (2002)
Randomized controlled trial of clarithromycin and ethambutol in the treatment of Crohn's disease
RW Goodgame et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2001)
Diagnosis and treatment of perianal fistulas in Crohn disease
DA Schwartz et al.
ANNALS OF INTERNAL MEDICINE (2001)
A prospective randomized controlled trial of intravenous ciprofloxacin as an adjunct to corticosteroids in acute, severe ulcerative colitis
GJ Mantzaris et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2001)
Adherent invasive Escherichia coli strains from patients with Crohn's disease survive and replicate within macrophages without inducing host cell death
AL Glasser et al.
INFECTION AND IMMUNITY (2001)
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Y Ogura et al.
NATURE (2001)
Age and disease related changes in intestinal bacterial popular-ions assessed by cell culture, 16S rRNA abundance, and community cellular fatty acid profiles
MJ Hopkins et al.
GUT (2001)
Screening of sulfate-reducing bacteria in colonoscopy samples from healthy and colitic human gut mucosa
V Zinkevich et al.
FEMS MICROBIOLOGY ECOLOGY (2000)
Inflammatory bowel disease: epidemiology and management in an English general practice population
GP Rubin et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2000)
Is Lactobacillus GG helpful in children with Crohn's disease?: Results of a preliminary, open-label study
P Gupta et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2000)
In vitro activity and fecal concentration of rifaximin after oral administration
ZD Jiang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial
P Gionchetti et al.
GASTROENTEROLOGY (2000)
Saccharomyces boulardii in maintenance treatment of Crohn's disease
M Guslandi et al.
DIGESTIVE DISEASES AND SCIENCES (2000)
Use of short-term culture for identification of Mycobacterium avium subsp paratuberculosis in tissue from Crohn's disease patients
D Schwartz et al.
CLINICAL MICROBIOLOGY AND INFECTION (2000)
Causation of Crohn's disease by Mycobacterium avium subspecies paratuberculosis
J Hermon-Taylor et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2000)
Combination of antibiotic and probiotic treatment is efficacious in prophylaxis of post-operative recurrence of Crohn's disease: A randomized controlled study vs mesalamine.
M Campieri et al.
GASTROENTEROLOGY (2000)
Colonic bacteria express an ulcerative colitis pANCA-related protein epitope
O Cohavy et al.
INFECTION AND IMMUNITY (2000)
Fat composition is the differential factor to explain the primary therapeutic effect of enteral nutrition in Crohn's disease. Results of a double-blind, randomized, Multicenter European Trial.
MA Gassull et al.
GASTROENTEROLOGY (2000)
A simple classification of Crohn's disease: Report of the Working Party for the world congresses of gastroenterology, Vienna 1998
C Gasche et al.
INFLAMMATORY BOWEL DISEASES (2000)
The contribution of sulphate reducing bacteria and 5-aminosalicylic acid to faecal sulphide in patients with ulcerative colitis
MCL Pitcher et al.
GUT (2000)
Characterization of antibody responses against rectal mucosa-associated bacterial flora in patients with ulcerative colitis
H Matsuda et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2000)
分享论文
